<DOC>
	<DOC>NCT01789905</DOC>
	<brief_summary>To retrospectively collect the effectiveness and safety information of tigecycline related to their appropriate use in daily practice.</brief_summary>
	<brief_title>Tygacil Drug Use Investigation</brief_title>
	<detailed_description />
	<mesh_term>Skin Diseases</mesh_term>
	<mesh_term>Intraabdominal Infections</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Skin Diseases, Infectious</mesh_term>
	<mesh_term>Tigecycline</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>All patients who are prescribed tigecycline (Tygacil). Subject who have been prescribed tigecycline (Tygacil).</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Tygacil</keyword>
	<keyword>Tigecycline</keyword>
	<keyword>Post marketing surveillance</keyword>
	<keyword>Japanese</keyword>
	<keyword>Infection</keyword>
</DOC>